Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2
Study Phase: N/A
Recruitment Status: Recruiting
Start Date: April 01, 2019
End Date: September 01, 2022
Inclusion Criteria:
- Mild cognitive impairment
- Mild Alzheimer's Disease with an MMSE score of >19 or Clinical Dementia Rating of 0.5 or 1.
- Sleep Disturbance
- Live at home
Exclusion Criteria:
- Blindness
- insulin-dependent diabetes patients
- macular degeneration
- severe sleep apnea
-
Conditions:
- Alzheimer Disease
- Metabolic Syndrome
- Cognitive Dysfunction